The embryo research is currently banned in France. By way of derogation, the revised bioethics law in 2011, however, allows the realization of research justified by a major medical interest, provided that the relevant scientific studies is justified, it is not possible to conduct similar studies in the using cells from an embryo and not the rules of ethics are respected, particularly with regard to the signing of informed consent by the couple whose embryo came they sought their destruction before one is proposed possible use for research. This research is strictly supervised by the Biomedicine Agency ensures that at each stage of their compliance with legal and ethical rules.
Thus, all research on lines of human embryonic stem cells as the cells of various phenotypes derived from these lines should aim to lexploration mechanisms or the development and validation of therapeutic applicable to serious diseases . I-Stem does not participate, directly or indirectly, to programs authorized by the Biomedicine Agency and conducted under its control.
The laboratory, in the project I-Stem, received the first approval by the Biomedicine Agency, for importation into France of hES cell lines from abroad in accordance with current legislative framework. Inspected by the Agency on a regular basis, I-Stem received after each visit a report entirely favorable, without amendment application, both for its facilities, procedures for compliance with its commitments to projects.
- Read our thematic file on “French Bioethics law : definitive adoption of the bioethics law on the embryonic stem cells research (june, 23rd, 2011)”
Researchers from I-Stem participate regularly in discussions on the ethical reflection on scientific and medical perspectives of research on human embryonic stem cells. Scientific Director of I-Stem is regularly interviewed by various committees and councils whose opinion is sought by the Parliament on these issues, as well as interviews conducted by the elected National Assembly and the Senate.